Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
- 30 June 2013
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 58 (6), 1181-1187
- https://doi.org/10.1016/j.jhep.2013.01.039
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Modified RECIST (mRECIST) Assessment for Hepatocellular CarcinomaSeminars in Liver Disease, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Chemoembolization for hepatocellular carcinomaGastroenterology, 2004
- Primary liver cancer: Worldwide incidence and trendsGastroenterology, 2004
- End Points and United States Food and Drug Administration Approval of Oncology DrugsJournal of Clinical Oncology, 2003
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalJournal of Hepatology, 2003
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999
- Reporting results of cancer treatmentCancer, 1981